Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis (vol 41, pg 941, 2021)

Por: Carlos,, Barrios, V, Lip, GYH, Amin, AN, Auladell-Rispau, A, Santero, M, Salazar, J, Requeijo, C

Publicada: 1 mar 2022 Ahead of Print: 1 feb 2022

Web: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124747515&doi=10.1007%2fs40261-022-01126-w&partnerID=40&md5=252ff3ef7b699e999a53af00fb4ce26f

Resumen:
[No abstract available]

Filiaciones:
Carlos,:
Hosp Univ La Paz, Serv Cardiol, Paseo Castellana 261, Madrid 28046, Spain

Barrios, V:
Hosp Univ Ramon & Cajal, Serv Cardiol, Madrid, Spain

Lip, GYH:
Univ Liverpool, Liverpool, Merseyside, England

Liverpool Heart & Chest, Liverpool, Merseyside, England

Amin, AN:
Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA USA

Auladell-Rispau, A:
Inst Invest Biomed Sant Pau IIB Sant Pau, Grup Recerca Epidemiol Clin Serveis Sanitari, Barcelona, Spain

Santero, M:
Inst Invest Biomed Sant Pau IIB Sant Pau, Grup Recerca Epidemiol Clin Serveis Sanitari, Barcelona, Spain

Salazar, J:
Inst Invest Biomed Sant Pau IIB Sant Pau, Grup Recerca Epidemiol Clin Serveis Sanitari, Barcelona, Spain

Requeijo, C:
Inst Invest Biomed Sant Pau IIB Sant Pau, Grup Recerca Epidemiol Clin Serveis Sanitari, Barcelona, Spain

ISSN: 11732563

CLINICAL DRUG INVESTIGATION

Editorial
ADIS INT LTD, 5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND, Nueva Zelanda

Tipo de documento: Correction
Volumen: 42 Número: 3
Páginas: 279-280

DOI: 10.1007/s40261-022-01126-w

WOS Id: 000756348000001

ID de PubMed: 35157250

Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis (vol 41, pg 941, 2021)

MÉTRICAS